Lonial Spotlights CAR T-Cell and Off-the-Shelf Treatments in Multiple Myeloma
Sagar Lonial, MD, FACP, details how CAR T-cell therapies and off-the-shelf treatments are improving outcomes for patients with multiple myeloma.
Source: onclive.com
Stay updated with breaking news from Karmma 3. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sagar Lonial, MD, FACP, details how CAR T-cell therapies and off-the-shelf treatments are improving outcomes for patients with multiple myeloma.
Krina Patel, MD, reviews data from the CARTITUDE-4 and KarMMa-3 studies and shares perspectives on a potential role for CAR T-cell therapy at early relapse.
Experts discuss the recent data presented at ASH 2023 from the KarMMA-3 trial in which ide-cel vs standard of care was studied in triple class exposed R/R MM patients.